@ChildrensPhila @PennMedicine neonatologist & researcher; focus on Rx for neonatal lung disease. Ops lead @EBNEO. Assoc Ed @CochraneNeonate #NeoEBM πͺπ¨πΊπΈ
Philadelphia, PA
Joined December 2012
- Tweets4.1K
- Following1.3K
- Followers2.8K
- Likes5.7K
Nicolas A. Bamat, MD MSCE retweeted
Day 1 on our annual symposium! From BPD-prematurity is a life long disease! to Developmental care; PH and inhaled meds! @neo_twiter @EBNEO @NeoConsortium @nbamat @nicupodcast
Nicolas A. Bamat, MD MSCE retweeted
As of today 240! Incredible growth, 104 for dinner, 31 posters! @EBNEO @neo_twiter @NeoConsortium @nicupodcast @What_Baker_Said @nbamat @kaashif_ahmad @MilenkaCuevas
Nicolas A. Bamat, MD MSCE retweeted
Letβs submit the votes for the most impactful publication!
#neoEBM
Nicolas A. Bamat, MD MSCE retweeted
Select the finalists for the 2023 @EBNeo Impact Article of the Year! π
buff.ly/3R5JhMy
Which of these 8 great publication will have the most impact on neonatal care?
#EBNeoImpact23 #neoebm #neoTwitter
Nicolas A. Bamat, MD MSCE retweeted
Introducing the #EBNeoImpact23 nominees!
This UCM vs DCC trial was published in Pediatrics - buff.ly/41Lqn36 - and disseminated via #ebneoalerts on 11/11/23.
Did it impact your neonatal practice?
Share your experience with the #neoebm and #neoTwitter community!
Nicolas A. Bamat, MD MSCE retweeted
Introducing the #EBNeoImpact23 nominees!
The IMPACT trial was published in Pediatrics - buff.ly/41NUUh2 - & disseminated via #ebneoalerts on 8/12/23. Open access #ebneoreviews: buff.ly/48JVNrl
Did it impact your practice?
Share your experience!
Nicolas A. Bamat, MD MSCE retweeted
Sharing our new paper led by @Dr_Rasheda with @BrianKingNeo
@Dr_KSGautham & @souvik_neo (from workshop in #PAS2023)
Navigating Information Overload on Social Media: Opportunities and Misadventures for Clinicians and Professionals
newbornjournal.org/abstractAβ¦
#neoEBM @EBNEO @ESPR_ESN
Nicolas A. Bamat, MD MSCE retweeted
Introducing the #EBNeoImpact23 nominees!
The MATISSE trial was published in @NEJM
buff.ly/418aHni - and disseminated via #ebneoalerts on 5/13/23.
Did it impact your neonatal practice?
Share your experience with the #neoebm and #neoTwitter community!
Nicolas A. Bamat, MD MSCE retweeted
Introducing the #EBNeoImpact23 nominees!
The SafeBoosC-III trial was published in @NEJM - buff.ly/3UWNW3E - and disseminated via #ebneoalerts on 4/22/23.
Did it impact your neonatal practice?
Share your experience with the #neoebm and #neoTwitter community!
Nicolas A. Bamat, MD MSCE retweeted
It's time for the 5th @EBNEO Impact Article of the Year campaign! We'll close 2024 by reviewing #neoebm highlights from 2023. A year from dissemination, have these pubs impacted your neonatal care?
β
Consider the 8 nominees by following the links: buff.ly/3R5JhMy
1/2
Nicolas A. Bamat, MD MSCE retweeted
β
Follow posts of their initial #ebneoalerts and #ebneoreviews in the coming days
β
Vote for the 2 finalists & choose the most impactful article on ebneo.org on 12/29 and 12/31
β
Tune in to a campaign wrap-up with @nicupodcast in early 2025
#EBNeoImpact23
2/2
Nicolas A. Bamat, MD MSCE retweeted
#neotwitter What do you think are the major controversies in the field of bronchopulmonary dysplasia? If you've worked at multiple locations, what are the major practice variations and what causes most disagreement in this field?
Nicolas A. Bamat, MD MSCE retweeted
Our buddy @nbamat from @ebneo joins us to discuss polypharmacy and Furosemide use in the #nicu at @hottopicsneo! Keep an eye out for the EBNEO Article of the year!!
#neotwitter
buff.ly/49zFCht
To determine dosing of common medications in preterm infants, I rely on ___________ for guidance.
Please RT π
#neotwitter #neoebm
32%Lexicomp (Pedi & Neo)
55%Neofax/Micromedex
13%Other (please comment!)
47 votes β’ Final results Nicolas A. Bamat, MD MSCE retweeted
Thanks for coverage @ebneo! Clarification: infants admitted to centers with a tendency towards later tracheostomy had increased *survival to discharge without tracheostomy
Nicolas A. Bamat, MD MSCE retweeted
Had the honor of presenting my research about inequities in pediatric patient-centered medical homes at @PASMeeting #PAS2024 during the @AmerAcadPeds Presidential Plenary!
Nicolas A. Bamat, MD MSCE retweeted
Lots of great conversations at our #PASMeeting booth number #307! Stop by to meet our team and learn about our resources. ms.spr.ly/6019YrwAU
Nicolas A. Bamat, MD MSCE retweeted
In preterms in the PENUT trial receiving Rx for PDA, indomethacin found to have a greater association with a lower eGFR at 2y compared to ibuprofen or acetaminophen.
Work from @conditpaige @triplebadger10
#neoebm #neotwitter #pas2024
Nicolas A. Bamat, MD MSCE retweeted
Mr. Netanyahu, antisemitism is a vile and disgusting form of bigotry that has done unspeakable harm to millions.
Do not insult the intelligence of the American people by attempting to distract us from the immoral and illegal war policies of your extremist and racist government.